PlainRecalls
FDA Drug Moderate Class II Ongoing

Amphotericin B Liposome for Injection, 50mg vials, Rx only, Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Medicare Limited, Baska Ujeti Road, Ujeti Halol-389350, Gujarat, India. NDC 62756-233-01

Reported: May 15, 2024 Initiated: April 19, 2024 #D-0493-2024

Product Description

Amphotericin B Liposome for Injection, 50mg vials, Rx only, Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Medicare Limited, Baska Ujeti Road, Ujeti Halol-389350, Gujarat, India. NDC 62756-233-01

Reason for Recall

Out of specification for assay

Details

Units Affected
11,016 vials
Distribution
Nationwide within the United States
Location
Princeton, NJ

Frequently Asked Questions

What product was recalled?
Amphotericin B Liposome for Injection, 50mg vials, Rx only, Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Medicare Limited, Baska Ujeti Road, Ujeti Halol-389350, Gujarat, India. NDC 62756-233-01. Recalled by SUN PHARMACEUTICAL INDUSTRIES INC. Units affected: 11,016 vials.
Why was this product recalled?
Out of specification for assay
Which agency issued this recall?
This recall was issued by the FDA Drug on May 15, 2024. Severity: Moderate. Recall number: D-0493-2024.